CareLit · DOI-Nachweis · Pneumologie
Mechanisms underlying acquired resistance to tyrosine kinase inhibitors in lung cancer
DOI 10.1055/s-0029-1247951
Bibliografische Angaben
Nachweis in CareLit
Autor:innenJ Simasi, A Schubert, A Gillissen
ZeitschriftPneumologie
Ausgabe01/2010
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Aims: The response to tyrosine kinase inhibitors in lung cancer patients is variable and some responding patients eventually acquire resistance to the drugs later on. The mechanism to this phenomenon has been related to mutations in the epidermal growth factor receptor. Our study aims at establishing other factors apart from T790M mutation which lead to acquired resistance to tyrosine kinase inhibitors Erlotinib and…
Zitieren
Zitierempfehlung
J Simasi, A Schubert, A Gillissen (2010) Mechanisms underlying acquired resistance to tyrosine kinase inhibitors in lung cancer. Pneumologie (01). https://doi.org/10.1055/s-0029-1247951
Mit CareLit weiterarbeiten